相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
C. Simmons et al.
ANNALS OF ONCOLOGY (2009)
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
Julie E. Lang et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
Marta Pestrin et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow-a long-term follow-up
I. J. Diel et al.
ANNALS OF ONCOLOGY (2008)
Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer - a phase II pilot study
B. Rack et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Immunohistochemical profiles of brain metastases from breast cancer
Kan Yonemori et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy
Alfredo Santinelli et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases:: a possible tool for anti-HER2 therapy management?
A. Vincent-Salomon et al.
BRITISH JOURNAL OF CANCER (2007)
Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients
Erich F. Solomayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients
P Wülfing et al.
CLINICAL CANCER RESEARCH (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer
JA Schardt et al.
CANCER CELL (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer
V Bozionellou et al.
CLINICAL CANCER RESEARCH (2004)
HER-2 gene amplification can be acquired as breast cancer progresses
SD Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Sequential immunochemotherapy and edrecolomab in the adjuvant therapy of breast cancer: reduction of 17-1A-positive disseminated tumour cells
EM Kirchner et al.
ANNALS OF ONCOLOGY (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells
D Hempel et al.
CYTOTHERAPY (2000)
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
S Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
